Paul Josephs - 08 Jul 2025 Form 4 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: LFCR
Reported as of: 08 Jul 2025
Net transaction value: -$449,279
SEC form: 4
Accepted by SEC: 10 Jul 2025, 16:41:00 UTC
Prior SEC filing: 22 May 2025
Next SEC filing: 21 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Aaron S. Perlitsh, Attorney-In-Fact for Paul Josephs

Key filing fact

Paul Josephs filed Form 4 for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) on 10 Jul 2025.

Key facts

This page summarizes Paul Josephs's Form 4 filing for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 10 Jul 2025, 16:41.

Change

Previous filing in this sequence was filed on 22 May 2025.
Current net transaction value: -$449,279.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002022547 Primary reporting owner

Josephs Paul

Relationship: Chief Executive Officer, Director
Address: C/O LIFECORE BIOMEDICAL, INC., 3515 LYMAN BLVD., CHASKA
Signature: /s/ Aaron S. Perlitsh, Attorney-In-Fact for Paul Josephs
Signature date: 10 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LFCR transaction

Common Stock

Options Exercise

Transaction value
Shares: +150,000
Change %: +28%
Price
Shares after: 688,185
Date: 08 Jul 2025
Ownership: Direct
Footnotes: F1, F2

LFCR transaction

Common Stock

Tax liability

Transaction value: $449,279
Shares: -54,857
Change %: -8%
Price: $8.19
Shares after: 633,328
Date: 08 Jul 2025
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LFCR transaction Derivative

Performance-Based Restricted Stock Units

Options Exercise

Transaction value
Shares: -150,000
Change %: -10%
Price
Shares after: 1,350,000
Date: 08 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 150,000
Exercise price
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The performance-based restricted stock units vested based on the Issuer's achievement of a stock price milestone.

Footnote F2

Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon the Issuer's common stock achieving certain stock prices.

Footnote F3

Represents number of shares withheld by the issuer to satisfy applicable tax withholding obligations in connection with the vesting and settlement of the performance stock unit award as reported in Table I.